Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
30.90
+0.55 (1.81%)
At close: Jul 7, 2025, 4:00 PM
32.49
+1.59 (5.15%)
After-hours: Jul 7, 2025, 5:35 PM EDT

Collegium Pharmaceutical Stock Forecast

Stock Price Forecast

The 4 analysts that cover Collegium Pharmaceutical stock have a consensus rating of "Strong Buy" and an average price target of $43.75, which forecasts a 41.59% increase in the stock price over the next year. The lowest target is $37 and the highest is $50.

Price Target: $43.75 (+41.59%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $37 $43.75 $46 $50
Change +19.74% +41.59% +48.87% +61.81%
* Price targets were last updated on May 9, 2025.

Analyst Ratings

The average analyst rating for Collegium Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Feb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy 444443
Buy 000000
Hold 111111
Sell 000000
Strong Sell 000000
Total 555554

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Piper Sandler
Piper Sandler
Hold
Reiterates
$36$37
Hold Reiterates $36$37 +19.74% May 9, 2025
Needham
Needham
Strong Buy
Reiterates
$46
Strong Buy Reiterates $46 +48.87% Apr 9, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$50
Strong Buy Reiterates $50 +61.81% Mar 24, 2025
Piper Sandler
Piper Sandler
Hold
Maintains
$37$36
Hold Maintains $37$36 +16.50% Feb 4, 2025
Needham
Needham
Strong Buy
Upgrades
$46
Strong Buy Upgrades $46 +48.87% Jan 10, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
757.96M
from 631.45M
Increased by 20.04%
Revenue Next Year
788.14M
from 757.96M
Increased by 3.98%
EPS This Year
7.97
from 1.86
Increased by 329.42%
EPS Next Year
8.09
from 7.97
Increased by 1.48%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
310.02M276.87M463.93M566.77M631.45M757.96M788.14M736.18M
Revenue Growth
4.49%-10.69%67.57%22.17%11.41%20.04%3.98%-6.59%
EPS
0.761.86-0.741.291.867.978.097.60
EPS Growth
-144.25%--43.56%329.42%1.48%-6.12%
Forward PE
-----3.883.824.07
No. Analysts
-----776
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 786.7M 840.9M 871.4M
Avg 758.0M 788.1M 736.2M
Low 722.1M 732.4M 576.7M

Revenue Growth

Revenue Growth 20252026202720282029
High
24.6%
10.9%
10.6%
Avg
20.0%
4.0%
-6.6%
Low
14.4%
-3.4%
-26.8%

EPS Forecast

EPS 20252026202720282029
High 11.13 11.20 10.50
Avg 7.97 8.09 7.60
Low 6.62 6.22 3.68

EPS Growth

EPS Growth 20252026202720282029
High
499.2%
40.5%
29.8%
Avg
329.4%
1.5%
-6.1%
Low
256.8%
-21.9%
-54.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.